Your browser doesn't support javascript.
loading
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.
Jansen, Valerie M; Bhola, Neil E; Bauer, Joshua A; Formisano, Luigi; Lee, Kyung-Min; Hutchinson, Katherine E; Witkiewicz, Agnieszka K; Moore, Preston D; Estrada, Mónica Valéria; Sánchez, Violeta; Ericsson, Paula G; Sanders, Melinda E; Pohlmann, Paula R; Pishvaian, Michael J; Riddle, David A; Dugger, Teresa C; Wei, Wenyi; Knudsen, Erik S; Arteaga, Carlos L.
Afiliação
  • Jansen VM; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bhola NE; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bauer JA; Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Formisano L; Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lee KM; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hutchinson KE; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Witkiewicz AK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Moore PD; Department of Pathology, University of Arizona, Tucson, Arizona.
  • Estrada MV; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sánchez V; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ericsson PG; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sanders ME; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pohlmann PR; Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pishvaian MJ; Department of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Riddle DA; Department of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
  • Dugger TC; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wei W; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Knudsen ES; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Arteaga CL; Department of Medicine, University of Arizona, Tucson, Arizona.
Cancer Res ; 77(9): 2488-2499, 2017 05 01.
Article em En | MEDLINE | ID: mdl-28249908
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Purinas / Neoplasias da Mama / Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / Aminopiridinas Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Purinas / Neoplasias da Mama / Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / Aminopiridinas Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article